Revive Therapeutics Ltd.
RVVTF·761516103·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic
CS
RVVTF (Revive Therapeutics Ltd.) is held by 0 institutional investors as of Q4 2024.
0
Holders
Avg rating
$0
Total Value
0% (1)
Fund Consensus
Smart Money Verdict
No institutional consensus yet
Fewer than 2 tracked funds currently hold RVVTF (Revive Therapeutics Ltd.). We surface convergence signals once 2+ institutional funds, insiders, or activists take a position.
This is the correct empty state for thinly-held stocks, not a data issue. New 13F filings arrive quarterly; insider and activist filings update daily.
13F: Insider & Congress:
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $158 | 0.0% | -97.14% | 0 |
